Company intelligence / Profile preview
Codagenix
Farmingdale, New York, United Statescodagenix.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Phase 3
01
Overview
Codagenix has advanced multiple live attenuated vaccine candidates into clinical trials. Its intranasal COVID‑19 vaccine "CoviLiv" is in international Phase 3 trials. RSV and influenza vaccines are in Phase 1 studies with promising preclinical results. The dengue vaccine program is advancing toward first-in-human studies with recent DoD funding support. Early oncology programs are expanding indications for solid tumor virotherapeutics.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Live attenuated viruses (vaccines and therapeutics)Oncolytic viruses (immuno-oncology)
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Serum Institute of India Pvt. Ltd. – manufacturing/development partner for CoviLiv COVID‑19 vaccineU.S. Department of Defense – funding/support for dengue programWorld Health Organization – CoviLiv included in Solidarity trial initiative
Beyond the preview
Go deeper on Codagenix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Codagenix.